Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
PUT
Procter & Gamble
PG
$335B
| $100M | 0.02% |
695,700
-480,600
| -41% | -$72.9M |
2013 Q2
51 quarters
|
|
802
CALL
Vertex Pharmaceuticals
VRTX
$127B
| $100M | 0.02% |
224,100
-24,300
| -10% | -$11.3M |
2013 Q2
51 quarters
|
|
803
W.P. Carey
WPC
$14.7B
| $100M | 0.02% |
1,471,676
+1,392,135
| +1,750% | +$97.7M |
2025 Q4
1 quarter
|
|
804
VSE Corp
VSEC
$4.52B
| $99.8M | 0.02% |
541,177
+396,699
| +275% | +$80.8M |
2025 Q2
3 quarters
|
|
805
CALL
Core Scientific
CORZ
$5.42B
| $99.6M | 0.02% |
6,656,800
-737,200
| -10% | -$12.6M |
2024 Q1
8 quarters
|
|
806
CAVA Group
CAVA
$6.31B
| $99.4M | 0.02% |
1,228,225
-110,417
| -8% | -$8.05M |
2023 Q2
11 quarters
|
|
807
Dynatrace
DT
$17.2B
| $99.1M | 0.02% |
2,679,807
+1,011,814
| +61% | +$38.7M |
2019 Q3
26 quarters
|
|
808
CALL
McKesson
MCK
$103B
| $99.1M | 0.02% |
114,500
-59,200
| -34% | -$52.8M |
2013 Q2
51 quarters
|
|
|
809
Procter & Gamble
PG
$335B
| $99M | 0.02% |
685,435
-811,481
| -54% | -$123M |
2024 Q3
6 quarters
|
|
810
Lumentum
LITE
$93.4B
| $98.9M | 0.02% |
140,747
+49,069
| +54% | +$27M |
2015 Q3
42 quarters
|
|
811
CALL
S&P Global
SPGI
$113B
| $98.8M | 0.02% |
232,300
+9,700
| +4% | +$4.5M |
2016 Q2
39 quarters
|
|
812
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.22B
| $98.6M | 0.02% |
1,588,200
+799,300
| +101% | +$52.4M |
2016 Q3
38 quarters
|
|
813
Newmont
NEM
$122B
| $98.6M | 0.02% |
910,588
+258,400
| +40% | +$29.8M |
2013 Q2
51 quarters
|
|
814
PUT
Halliburton
HAL
$26.6B
| $98.3M | 0.02% |
2,520,900
-1,093,300
| -30% | -$37.8M |
2013 Q2
51 quarters
|
|
815
CALL
iShares Semiconductor ETF
SOXX
$50.5B
| $98.3M | 0.02% |
299,000
-403,900
| -57% | -$138M |
2017 Q1
36 quarters
|
|
816
Hormel Foods
HRL
$11B
| $98.2M | 0.02% |
4,335,830
-1,656,685
| -28% | -$39.6M |
2019 Q3
26 quarters
|
|
817
CALL
Expedia Group
EXPE
$31.8B
| $98.1M | 0.02% |
424,900
-123,600
| -23% | -$30.4M |
2013 Q2
51 quarters
|
|
818
CALL
Applied Optoelectronics
AAOI
$9.3B
| $98.1M | 0.02% |
1,159,200
+762,400
| +192% | +$48.6M |
2015 Q2
43 quarters
|
|
819
CALL
Celestica
CLS
$48.3B
| $98.1M | 0.02% |
348,100
-385,000
| -53% | -$112M |
2022 Q4
13 quarters
|
|
820
Virtu Financial
VIRT
$5.18B
| $98M | 0.02% |
2,228,582
+438,993
| +25% | +$17.1M |
2015 Q2
43 quarters
|
|
821
Mirum Pharmaceuticals
MIRM
$5.44B
| $97.2M | 0.02% |
1,052,048
+211,828
| +25% | +$19.9M |
2021 Q3
18 quarters
|
|
822
PUT
United Therapeutics
UTHR
$24B
| $97.1M | 0.02% |
163,800
+113,800
| +228% | +$56.7M |
2013 Q2
51 quarters
|
|
823
PUT
Thermo Fisher Scientific
TMO
$240B
| $97.1M | 0.02% |
197,600
-154,100
| -44% | -$83.6M |
2013 Q2
51 quarters
|
|
824
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$1.91B
| $96.9M | 0.02% |
2,687,800
+1,208,850
| +82% | +$46M |
2016 Q3
38 quarters
|
|
825
TKO Group
TKO
$12.8B
| $96.8M | 0.02% |
479,997
+347,414
| +262% | +$71M |
2023 Q3
10 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.